Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas Meeting Abstract

  

Authors:	Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
Abstract Title:	Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas
Meeting Title:	15th World Conference on Lung Cancer (IASLC)
Keywords:	neoadjuvant chemotherapy; surrogate endpoint; pathologic response; nodal downstaging
Journal Title:	Journal of Thoracic Oncology
Volume:	8
Issue:	Suppl. 2
Meeting Dates:	2013 Oct 27-31
Meeting Location:	Sydney, Australia
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2013-11-01
Start Page:	S137
Language:	English
ACCESSION:	WOS:000339624900161
PROVIDER:	wos
DOI:	10.1097/01.JTO.0000438438.14562.c8
Notes:	Meeting Abstract: O02.05 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/65524